Mary Jordan Armstrong
Family · Northport, ALNPI 1669977443
Payments from drug & device makers
Across 515 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$1K
- Lilly USA, LLC$983
- Pfizer$946
- Novo Nordisk$755
- Corium, LLC$450
- plus $3K from 28 others
What the payments were for
- Food & beverage$8,141100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $1,291 |
| GSK | 77 | $1,027 |
| Lilly USA, LLC | 62 | $983 |
| Pfizer | 55 | $946 |
| Novo Nordisk | 60 | $755 |
| Corium, LLC | 21 | $450 |
| Boehringer Ingelheim | 20 | $305 |
| AstraZeneca | 18 | $280 |
| Exact Sciences | 14 | $222 |
| Bayer | 10 | $214 |
| Merck | 14 | $208 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $150 |
| Johnson & Johnson | 9 | $135 |
| Daiichi Sankyo Inc. | 6 | $131 |
| Amarin Pharma, Inc. | 6 | $108 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 7 | $86 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Atland Pharmaceuticals, LLC | 1 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Almatica Pharma LLC | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Amgen | 1 | $19 |
| Abbott | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Novartis | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$8,141 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 70 | $75,249 |
| JardianceEmpagliflozin | 32 | $40,013 |
| EliquisApixaban | 29 | $32,903 |
| OzempicSemaglutide | 19 | $27,653 |
| FarxigaDapagliflozin Propanediol | 22 | $25,039 |
| XareltoRivaroxaban | 27 | $19,528 |
| LinzessLinaclotide | 14 | $15,199 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $4,804 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,566 |
| Febuxostat | 11 | $1,922 |
| Atorvastatin Calcium | 216 | $1,909 |
| Rosuvastatin Calcium | 89 | $1,498 |
| Nebivolol Hcl | 24 | $1,454 |
| ValacyclovirValacyclovir Hcl | 38 | $1,391 |
| FenofibrateFenofibrate Nanocrystallized | 25 | $1,322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $983 | $75,24970 claims |
| Boehringer IngelheimJardiance | $305 | $40,01332 claims |
| PfizerEliquis | $946 | $32,90329 claims |
| Novo NordiskOzempic | $755 | $27,65319 claims |
| AstraZenecaFarxiga | $280 | $25,03922 claims |
| Johnson & JohnsonXarelto | $135 | $19,52827 claims |
| AbbVieLinzess | $1,291 | $15,19914 claims |
| GSKAnoro Ellipta | $1,027 | $4,80411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.
Other family in Northport
- Lauren PerkinsNorthport$18K
- Mitchell CagleNorthport$13K
- Staci HardwickNorthport$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.